Literature DB >> 18654884

Unstable and thalassemic alpha chain hemoglobin variants: a cause of Hb H disease and thalassemia intermedia.

Henri Wajcman1, Jan Traeger-Synodinos, Ioannis Papassotiriou, Piero C Giordano, Cornelis L Harteveld, Véronique Baudin-Creuza, John Old.   

Abstract

We report an update of the alpha-globin gene point mutations resulting in structural modification associated with an alpha-thalassemia (alpha-thal) phenotype. These variants, barely symptomatic in the heterozygous state, are either unstable due to folding defects and/or defects in binding to alpha-hemoglobin stabilizing protein (AHSP). This is predicted to result in precipitation of the unstable alpha chains or Hb variant, a concomitant decrease in the overall quantity of normal alpha-globin in the red cells and a potential degree of anemia and possibly, hemolysis. Genotype/phenotype correlation and potential genetic risk in combination with common or less common alpha-thal defects are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18654884     DOI: 10.1080/03630260802173833

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  17 in total

1.  Insights into hemoglobin assembly through in vivo mutagenesis of α-hemoglobin stabilizing protein.

Authors:  Eugene Khandros; Todd L Mollan; Xiang Yu; Xiaomei Wang; Yu Yao; Janine D'Souza; David A Gell; John S Olson; Mitchell J Weiss
Journal:  J Biol Chem       Date:  2012-01-27       Impact factor: 5.157

2.  Α case of late diagnosis of compound heterozygosity for Hb Adana (HBA2:c.179G>A) in trans to an α+- thalassemia deletion: guilty or innocent.

Authors:  A Tampaki; S Theodoridou; Ch Apostolou; E E Delaki; E Vlachaki
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

3.  Coinheritance of Sicilian (δβ)0-Thalassemia and Two Rare Hemoglobin Variants: A Complex Case of Hemoglobinopathy.

Authors:  Hajar Eftekhari; Maryam Pilehchian Langroudi; Ali Banihashemi; Mandana Azizi; Reza Youssefi Kamangar; Haleh Akhavan-Niaki
Journal:  Indian J Clin Biochem       Date:  2017-07-05

4.  Iron deficiency anemia interfering the diagnosis of compound heterozygosity for Hb constant spring and Hb Paksé: The first case report.

Authors:  Thita Chiasakul; Noppacharn Uaprasert
Journal:  J Clin Lab Anal       Date:  2017-02-28       Impact factor: 2.352

Review 5.  Hemoglobin variants: biochemical properties and clinical correlates.

Authors:  Christopher S Thom; Claire F Dickson; David A Gell; Mitchell J Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

6.  Spectroscopic investigation on the toxicological interactions of 4-aminoantipyrine with bovine hemoglobin.

Authors:  Yue Teng; Rutao Liu; Shifeng Yan; Xingren Pan; Pengjun Zhang; Meijie Wang
Journal:  J Fluoresc       Date:  2009-09-29       Impact factor: 2.217

Review 7.  Alpha-thalassaemia.

Authors:  Cornelis L Harteveld; Douglas R Higgs
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

8.  Hydrops fetalis associated with homozygosity for Hb Adana [alpha59(E8)Gly-->Asp (alpha2)].

Authors:  Ita M Nainggolan; Alida Harahap; Iswari Setianingsih
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

9.  Chronic hemolytic anemia due to novel alpha-globin chain variants: critical location of the mutation within the gene sequence for a dominant effect.

Authors:  Claude Préhu; Kamran Moradkhani; Jean Riou; Michel Bahuau; Pierre Launay; Natacha Martin; Henri Wajcman; Michel Goossens; Frédéric Galactéros
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

10.  Hb H disease resulting from the association of an α-thalassemia allele [-(α)] with an unstable α-globin variant [Hb Icaria]: First report on the occurrence in Brazil.

Authors:  Elza M Kimura; Denise M Oliveira; Kleber Fertrin; Valéria R Pinheiro; Susan E D C Jorge; Fernando F Costa; Maria de Fátima Sonati
Journal:  Genet Mol Biol       Date:  2009-12-01       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.